Earnings · China A-shares
Guizhou Xinbang Pharmaceutical Co., Ltd. Class A (002390) earnings
Guizhou Xinbang Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit +11.88% year on year, -12.19% excluding one-off items. Wave Radar's earnings-quality score is 90 of 100 (Sound). The stock moved +13.09% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- +11.88%
- Excl. one-offs YoY
- -12.19%
- Net profit QoQ
- +39.08%
- Result
- Neutral
- Quality score
- 90
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +5.82% | — |
| 3 days | +13.09% | — |
| 7 days | +10.91% | — |
| 14 days | +7.27% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +2.07%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥170.42M | +11.88% | -12.19% | -14.16% | 0.09 | 2.50% | +13.09% | — | — |
| 2026 interim report | 2026-08-28 | ¥99.59M | -7.10% | -28.13% | -13.29% | 0.05 | 1.46% | +0.32% | -7.14% | +2.55% |
| 2026 Q1 report | 2026-04-29 | ¥48.66M | +17.97% | +14.78% | -12.34% | 0.03 | 0.71% | +5.97% | -8.81% | -9.75% |
| 2025 annual report | 2026-04-21 | ¥120.29M | +18.65% | -47.31% | -6.84% | 0.06 | 1.79% | -1.55% | -8.39% | -11.83% |
| 2025 Q3 report | 2025-10-29 | ¥152.32M | -13.74% | -10.50% | -6.55% | 0.08 | 2.25% | -0.52% | -1.82% | +1.65% |
| 2025 interim report | 2025-08-30 | ¥107.20M | -6.69% | -7.16% | -6.62% | 0.06 | 1.59% | -0.28% | +5.51% | +4.67% |
| 2025 Q1 report | 2025-04-30 | ¥41.24M | -29.89% | -30.16% | -8.93% | 0.02 | 0.61% | +2.93% | +3.52% | +0.34% |
| 2024 annual report | 2025-04-15 | ¥101.38M | -64.70% | -38.29% | -6.63% | 0.05 | 1.50% | -3.41% | +0.57% | -2.45% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.